Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 38251-38300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05953285
The Impact of Sleep Restriction on Gastric Emptying, Appetite and Energy Intake
NARecruiting
12 participants
Started: Jul 15, 2023 · Completed: Jan 17, 2024
1 condition1 sponsor1 location
NCT05926271
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
PHASE2Recruiting
200 participants
Started: Jul 15, 2023 · Completed: Jan 15, 2027
2 conditions1 sponsor1 location
NCT05444335
Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years
NARecruiting
120 participants
Started: Jul 15, 2023 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT05947487
CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 15, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05890677
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NARecruiting
280 participants
Started: Jul 14, 2023 · Completed: Jun 30, 2036
1 condition4 sponsors30 locations
NCT05573802
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
PHASE1/PHASE2Recruiting
36 participants
Started: Jul 14, 2023 · Completed: Oct 31, 2026
8 conditions2 sponsors2 locations
NCT05984602
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
PHASE1Recruiting
10 participants
Started: Jul 14, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor3 locations
NCT05780684
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NARecruiting
36 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT05808634
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
PHASE1Recruiting
168 participants
Started: Jul 14, 2023 · Completed: Sep 15, 2028
1 condition1 sponsor9 locations
NCT05480384
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
PHASE2Recruiting
25 participants
Started: Jul 14, 2023 · Completed: Sep 30, 2027
4 conditions2 sponsors2 locations
NCT04874454
Evaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke
NARecruiting
200 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05977816
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
NARecruiting
2,000 participants
Started: Jul 14, 2023 · Completed: Jul 31, 2026
3 conditions1 sponsor11 locations
NCT06803251
The Role of the Vascular Surgeon in Oncologic Surgery of Abdominal and Pelvic Retroperitoneal Masses
N/ARecruiting
70 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06270602
The ONCOCAMP Study
N/ARecruiting
15,000 participants
Started: Jul 14, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor17 locations
NCT05606237
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
NARecruiting
90 participants
Started: Jul 14, 2023 · Completed: Jul 14, 2025
1 condition2 sponsors1 location
NCT05950802
Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
PHASE1Recruiting
40 participants
Started: Jul 14, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06061094
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
PHASE2Recruiting
220 participants
Started: Jul 14, 2023 · Completed: Jul 1, 2029
1 condition3 sponsors85 locations
NCT05680012
Tissue Destruction and Healing in Celiac Disease
NARecruiting
220 participants
Started: Jul 14, 2023 · Completed: Jun 30, 2027
1 condition4 sponsors3 locations
NCT06855446
Interactive Mirroring Games wIth sOcial Robot (IOGIOCO) and Robotic System Adapted Into a Clinical Scale (RISCALE)
NARecruiting
40 participants
Started: Jul 14, 2023 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT05687682
Safety of AM-928 Infusion in Advanced Solid Tumors
PHASE1Recruiting
38 participants
Started: Jul 14, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05880160
Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction
NARecruiting
90 participants
Started: Jul 14, 2023 · Completed: Sep 30, 2025
4 conditions4 sponsors2 locations
NCT06860698
The Impact of Chronic E-Cigarette Usage on Microvascular Health
N/ARecruiting
44 participants
Started: Jul 14, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05613894
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1Recruiting
33 participants
Started: Jul 14, 2023 · Completed: May 1, 2028
1 condition2 sponsors1 location
NCT05994690
CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients
PHASE3Recruiting
905 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2035
1 condition2 sponsors1 location
NCT06069297
Prehabilitation in Pancreatic Surgery
NARecruiting
238 participants
Started: Jul 14, 2023 · Completed: May 31, 2027
5 conditions2 sponsors1 location
NCT05645718
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
PHASE2Recruiting
27 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05953480
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
PHASE2Recruiting
849 participants
Started: Jul 14, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor179 locations
NCT05940584
Tele-reha Versus Paper-based Aftercare Programme Following Inpatient Rehabilitation
NARecruiting
285 participants
Started: Jul 14, 2023 · Completed: Jan 14, 2025
1 condition2 sponsors1 location
NCT05981274
A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)
N/ARecruiting
45 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05669833
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
PHASE3Recruiting
63 participants
Started: Jul 14, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors14 locations
NCT05833360
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
N/ARecruiting
2,400 participants
Started: Jul 14, 2023 · Completed: Jul 14, 2030
1 condition1 sponsor2 locations
NCT07155148
Argentine Registry of Crohn's Disease and Ulcerative Colitis
N/ARecruiting
4,250 participants
Started: Jul 14, 2023 · Completed: Dec 30, 2027
3 conditions1 sponsor1 location
NCT05502250
Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission
PHASE2Recruiting
75 participants
Started: Jul 14, 2023 · Completed: Apr 30, 2030
1 condition2 sponsors15 locations
NCT06207851
Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist
NARecruiting
38 participants
Started: Jul 13, 2023 · Completed: Jul 13, 2026
1 condition1 sponsor1 location
NCT06776315
The Effect of Exercise Training on lncRNA Expression in Asthma
NARecruiting
84 participants
Started: Jul 13, 2023 · Completed: Jul 30, 2025
5 conditions1 sponsor1 location
NCT05982249
Hypnosis and Virtual Reality in Bone Marrow Examination
NARecruiting
100 participants
Started: Jul 13, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05807139
Spironolactone in Alcohol Use Disorder (SAUD)
PHASE1Recruiting
20 participants
Started: Jul 13, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06084169
Investigation for Assessing the Visual Performance of Hanita Lenses Intensity SL IOL in Comparison to Alcon Panoptix IOL
NARecruiting
58 participants
Started: Jul 13, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05589285
Outcomes of Autologous Whole Blood Injection for the Treatment of Plantar Fasciitis
NARecruiting
100 participants
Started: Jul 13, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05884866
A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
PHASE2Recruiting
100 participants
Started: Jul 13, 2023 · Completed: Jun 30, 2026
4 conditions1 sponsor2 locations
NCT05944237
HTL0039732 in Participants With Advanced Solid Tumours
PHASE1/PHASE2Recruiting
150 participants
Started: Jul 13, 2023 · Completed: Jun 30, 2027
14 conditions2 sponsors5 locations
NCT05868785
Effect of Nocturnal Parenteral Nutrition on Bone Turnover and Energy Metabolism
NARecruiting
20 participants
Started: Jul 13, 2023 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT05896007
Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
PHASE2Recruiting
29 participants
Started: Jul 13, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05751811
Effect of Virtual Reality and Music Therapy on Pain Relief in OPH Operations
NARecruiting
210 participants
Started: Jul 13, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05904379
AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
PHASE1/PHASE2Recruiting
233 participants
Started: Jul 13, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor2 locations
NCT06074900
The WHERE Study: Waiting for Hip and KneE REplacement
N/ARecruiting
3,008 participants
Started: Jul 13, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05824845
QIST Collaborative - Arthroplasty Research Cohort (ARC) Study
N/ARecruiting
5,000 participants
Started: Jul 13, 2023 · Completed: May 31, 2031
2 conditions2 sponsors1 location
NCT05982223
Integrative Medicine in Lymphoma Survivors
NARecruiting
90 participants
Started: Jul 13, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT05578235
Comparing Hand-sewn (END-TO-END or Kono-S) to Stapled Anastomosis in Ileocolic Resection for Crohn's Disease
NARecruiting
165 participants
Started: Jul 13, 2023 · Completed: Oct 1, 2027
1 condition2 sponsors1 location
NCT05508035
The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction
PHASE3Recruiting
666 participants
Started: Jul 13, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location